Cheyne Capital Management (UK)’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-52,790
Closed -$357K 35
2022
Q4
$357K Buy
+52,790
New +$357K 0.62% 42